The largest database of trusted experimental protocols

20 protocols using anti cd45ro pe

1

Memory CD4+ T Cell Isolation and Stimulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD4+CD45RO+ T cells were isolated from PBMC using the immunomagnetic negative selection EasySep Human Memory CD4+ T Cell Enrichment Kit and Magnet (StemCell Technologies, Vancouver, Canada), following manufacturer provided indications. Recovery (40.9±14.1%) and purity (93.6±1.2%) of the enriched population was assessed by flow cytometry, staining with PE-Cy7 anti-CD4 (BioLegend, San Diego, CA, USA), FITC anti-CD3, PE-Cy5 anti-CD8, APC anti-CD45RA and PE anti-CD45RO (BD Biosciences, San Diego, CA, USA) antibodies.
For initial stimulation, memory CD4+ T cells were seeded in 96-well plates, in T cell medium, at 5×103 cells/well and incubated with 104 autologous irradiated PBMC and 2.5 μg/ml T. cruzi epimastigote lysate, or at 103 cells/well and incubated with 104 allogeneic irradiated PBMC from 3 non-related, non-infected donors, 1 μg/ml PHA and 50 IU/ml IL-2. This interleukin was also added on every culture since day 3, every 3 to 4 days, at a final concentration of 50 IU/ml. Half the medium (100 μl/well) was refreshed every 10 to 14 days, beginning at day 15.
+ Open protocol
+ Expand
2

Comprehensive Flow Cytometry Immunophenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
Multi-parameter cytofluorometric analysis was performed to phenotype PBLs. The following conjugated monoclonal antibodies were purchased from BD Biosciences: peridinin chlorophyll protein complex–cyanine (PerCP-5–5)-anti-CD3, fluorescein isothiocyanate (FITC)-anti-CD4, allophycocyanin–cyanine (APC-Cy7)-anti-CD8, phycoerythrin–cyanine (PE-Cy7)-anti-CD25, PE–anti-FOXP3, PE-anti-CD45RO, FITC-anti-CD45RA, allophycocyanin (APC)-anti-CD45RA, and FITC-anti-Ki67. Cryopreserved cells were resuspended in a staining buffer supplied by the manufacturer (BD Biosciences, San Jose, CA) and stained for 20 min at 4 °C. The expression of FOXP3 was detected by intracellular staining of cells pre-stained with other markers and cell permeabilization was performed according to the manufacturer’s instructions (BD Biosciences). Samples were run on a FACSCanto flow cytometer (Becton Dickinson) with at least 5 × 104 events acquired per parameter. Sequential gating was used to discriminate lymphocyte subsets, as previously described.42 (link) Flow cytometry data were analyzed using the FloJo software package (Treestar).
+ Open protocol
+ Expand
3

Multiparametric Analysis of PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total PBMCs cells were stained with Pacific Blue anti-CD3 (BD 558117, clone UCHT1), PerCP-anti-CD4 (BD 566924, clone SK3), APC-Cy7-anti-CD8 (BD 557834, clone SK1), FITC-anti-CD45RA (BD 555488, clone HI100), and PE-anti-CD45RO (BD 555493, clone UCHL1) antibodies or APC-Cy7-anti-CD19 (BioLegend 302218, clone HIB19), Pacific Blue-anti-CD27 (BioLegend 356414, clone M-T271), FITC-anti-IgD (Life Technology H15501), and PerCP-anti-CD3 (BioLegend 300326, clone HIT3a). After 30 minutes of incubation, cells were washed, fixed, and permeabilized using the Foxp3/transcription factor staining buffer set (Thermo Fisher Scientific) according to the manufacturer’s instruction. Cells were then intracellularly stained with an Alexa Fluor 647-anti-AIOLOS antibody (BD 565215, clone S50-895) for an hour. Cells were acquired and analyzed by flow cytometry (Becton Dickinson FACSCanto II) and FlowJo software (FlowJo 10.8.2, TreeStar), respectively.
+ Open protocol
+ Expand
4

Phenotyping of T/CAR-T cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
T/CAR-T cells were centrifuged at 300×g for 5 minutes and resuspended in 100 μL PBS with 2% FBS. The T/CAR-T cells were stained at 4°C for 30 minutes with the following surface marker-specific antibodies: APC/Cy7-anti-CD25 (BD Pharmingen, San Diego, CA, USA), APC-anti-CD69 (BioLegend, San Diego, CA, USA), PE-anti-CD4 (BD Pharmingen), PE/Cy7-anti-CD8 (BioLegend), PE-anti-CD45RO (BD Pharmingen), APC-anti-CD62L (BD Pharmingen), PE-anti-PD-1 (BioLegend), PE/Cy7-anti-CTLA-4 (BioLegend), APC-anti-TIM-3 (BioLegend), and APC anti-human CD127 (BioLegend). The cells were then washed twice and resuspended in 400 μL PBS with 2% FBS for flow cytometry.
+ Open protocol
+ Expand
5

Phenotypic Analysis of Regulatory T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human peripheral blood mononuclear cells (PBMCs) were isolated from freshly drawn venous blood and BM mononuclear cells (BMMCs) were obtained from BM in both of OA and RA patients by Ficoll-Paque PLUS (GE Healthcare Biosciences AB, Uppsala, Sweden) density centrifugation. To examine the phenotype of regulatory T cells (Tregs), the following antibodies were used: anti-CD4-PerCP, anti-CD25-FITC, anti-CD127-PE, anti-CD45RA-FITC, anti-CD45RO-PE and anti-CD184 (CXCR4)-PE (all from BD Biosciences, San Jose, CA, USA). Next, cells were fixed and permeabilized using the Foxp3 Staining Buffer Set followed by intracellular staining with anti-Foxp3-APC antibody (PCH101; eBioscience, San Diego, CA, USA). Cells were acquired using FACSCalibur (BD Biosciences), and the results were analyzed using CellQuest (BD Biosciences) software. The gating strategy was based on the identification of lymphocytes according to FSC and SSC signal distribution. Then, CD4+ lymphocytes were gated, and next, appropriate cell populations were identified. Gates were settled according to the isotype control or fluorescence minus one (FMO) for the desired marker. The dot plots shown are representative for at least six experiments done on different patients. The described gating strategy is shown in Figure 2b and was used though all the analysis of the cell phenotype presented in this paper.
+ Open protocol
+ Expand
6

T-Cell Maturation and Phenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human CB T-cells, including those which were deficient in PKCζ, were maturated as previously described using phytohaemagglutinin (PHA) and IL-2 [22 (link),28 (link)]. Maturation was gauged by flow cytometry, measuring the expression of CD45RA and CD45RO using anti-CD45RA-APC, anti-CD45RO-PE, anti-CD3-FITC or isotype control mix (IgG2b-APC, IgG2a-PE and IgG1-FITC) antibodies (all BD Biosciences). The data were analysed on a BD FACScan using BD CellQuest software (BD Biosciences). Cultures were set up such that at each time point, a count was made and cell concentrations were re-adjusted based on the number of viable cells as described under ‘Results’ section.
+ Open protocol
+ Expand
7

Comprehensive Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-CD4-APC Cy7, anti-IFNγ–PE Cy7, anti-CCR5-pacific blue and anti-CCR6-Alexa Fluor 488 were purchased from Biolegend (CA). Anti-IL-1R1-PE, anti-IL-6R-PerCP, anti-CCR9-PE, anti-CXCR3-FITC, anti-IL-23p19 and control IgG were from R&D Systems (MN). Neutralizing anti-IL-1β and anti-IL-6/IL-6R were made in house. Anti-CD45RA-FITC, anti-CD45RO-PE, anti-integrin β7-PE, and anti-CD161-PE were purchased from BD Biosciences. Anti-IL-17-APC (eBioscience, CA) and anti-human IgG-PE (Jackson ImmunoResearch Laboratories, PA) were used. GolgiPlug was purchased from BD Pharmingen (CA). CFSE (Molecular probes, Oregon) was used for measuring CD4+ T cell proliferation. TLR ligands, including Pam(3)CysSK(4) were purchased from Invivogen (Oregon). Jak2 inhibitor (1,2,3,4,5,6-Hexabromocyclohexane), Jak3 inhibitor (4-(4′-Hydroxyphenyl)amino-6,7-dimethoxyquinazoline), pan Jak inhibitor (2-(1,1-Dimethylethyl)-9-fluoro-3,6-dihydro-7H-benz[h]-imidaz[4,5-f]isoquinolin-7-one), STAT5 inhibitor (Pimozide) and IRAK-1/4 inhibitor (N-(2-Morpholinylethyl)-2-(3-nitrobenzoylamido)-benzimidazole) were purchased from EMD chemicals (PA). STAT3 inhibitor (Stattic) was from Sigma-Aldrich (MO). MyD88 homodimerization inhibitory peptide (Imgenex, CA) was used. Anti-CD3/CD28 microbeads were purchased from Miltenyi Biotec (Germany).
+ Open protocol
+ Expand
8

Lymphocyte Immunophenotyping by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lymphocyte separation solution (TBD, Tianjin, China) was used to extract lymphocytes from blood samples. Cells were surface-labeled with anti-CD4-FITC (BD, California, USA), anti-CD8-PE antibody (BD, California, USA), anti-CD45RO-PE (BD, California, USA), or anti-CD38-PC5.5 (BD, California, USA) at 4 °C. The results of detection were analyzed using Kaluza v2.1.1 software.
+ Open protocol
+ Expand
9

Flow Cytometry Staining Reagents

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-CD3 FITC, anti-CD3 APC, anti-CD4 PerCP-cy5.5, anti-CD8-PerCP-cy5.5, anti-CD8 FITC, anti-CD45RO FITC, anti-CD45RO PE, anti-IFN-γ FITC, anti-IFN-γ APC, anti-IL-4 PE and isotype-matched control mAbs were purchased from BD PharMingen (San Diego, CA, USA). Anti-IL-22 PE was purchased from R&D Systems (Abingdon, UK). Anti-IL-17 APC was purchased from eBioscience (San Diego, CA, USA). Phorbol myristate acetate (PMA), ionomycin, saponin and Brefeldin A (BFA) were purchased from Sigma-Aldrich (Fluka, Sigma, USA).
+ Open protocol
+ Expand
10

Multi-Marker Phenotyping of T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-CD4 PerCP, Anti-CD4 PerCP-cy5.5, anti-CD3 APC, anti-CXCR5-Alexafluor 488, anti-CD45RO PE, anti-CCR7 PE, anti-CD28 PE, anti-CD69 PE, anti-HLA-DR PE, anti-IL-21 PE, anti-IL-4 PE, anti-IFN-γ APC and isotype-matched control mAbs were purchased from BD PharMingen (San Diego, CA, USA). Anti-IL-17 APC and ELISA for determining IL-21 was purchased from eBioscience (San Diego, CA, USA). Anti-IL-22 PE was purchased from R & D Systems (Abingdon, UK). PMA, ionomycin (INO), saponin and Brefeldin A were purchased from Sigma-Aldrich (Fluka, Sigma, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!